NCT00167167View on ClinicalTrials.gov

Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 1995

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Leukemia, Myeloid, ChronicAMLMDSLeukemia, Lymphocytic, Acute
Interventions
PROCEDURE

Donor Lymphocyte Infusion

"Certain immune cells in your donor's blood called lymphocytes have been shown to fight cancer after bone marrow transplantation. We plan to transfuse large numbers of donor's lymphocytes in the hope of activating the recipient's immune system to attack cancer."

Trial Locations (1)

55455

University of Minnesota Medical Center, Minneapolis

All Listed Sponsors
lead

Masonic Cancer Center, University of Minnesota

OTHER

NCT00167167 - Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia | Biotech Hunter | Biotech Hunter